Loading...

ARQT ARCUTIS BIOTHERAPEUTICS INC Earnings Reports 8-K Filing

RCTS

RQT

ARCUTIS BIOTHERAPEUTICS INC

(ARQT)

2023 8-K

Show Summary

Show Summary

Financial Statements

Management Change

Financial Results

Revenue Announcement

Financial Results

Financial Results

Annual Meeting of Stockholders

Earnings Reports

Appointment of CFO

Public Offering

License Agreement with Sato...

Earnings Reports

Stock Option Exchange Program

Option Exchange Program

Financial Results Press Rel...

Public Offering

Financial Results

Resignation of CFO

License Agreement with Hang...

Earnings Reports

Annual Meeting of Stockholders

Resignation of Senior VP

Earnings Reports

Earnings Reports

External Links:

Arcutis Biotherapeutics, Inc. discloses preliminary financial results for the three months ended September 30, 2023, including total revenues of approximately $38.1 million and cash of $228.1 million as of September 30, 2023.

AI Assistant

ARCUTIS BIOTHERAPEUTICS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.